CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue
Total revenue	$ 17,924	$ 4,598
Costs and expenses
Cost of goods sold	153,260	46,483
Research and development expenses	18,469	19,154
Selling, general and administrative expenses	60,623	42,998
Loss on pre-existing agreement	0	30,368
Loss from write-down of property, plant and equipment	6,846	50
Grant (income) expense, net	(16)	269
Total costs and expenses	239,182	139,322
Operating loss	(221,258)	(134,724)
Other (expense) income
Interest expense, net	(7,915)	(604)
Interest expense – related party	(10,898)	(4,597)
Remeasurement of equity method investment	0	(7,480)
Gain on change in fair value of derivatives - related parties	11,728	19,282
Income from equity in unconsolidated joint venture	0	440
(Loss) gain on debt (extinguishment)/forgiveness	(942)	1,273
Other (expense) income	(477)	2,194
Loss before income taxes	(229,762)	(124,216)
Income tax expense	51	0
Net loss	(229,813)	(124,216)
Other comprehensive income
Foreign currency translation adjustment, net of tax	6	0
Comprehensive loss	$ (229,807)	$ (124,216)
Basic and diluted loss per share attributable to common shareholders
Basic (in usd per share)	$ (3.68)	$ (2.36)
Diluted (in usd per share)	$ (3.68)	$ (2.36)
Weighted average shares of common stock
Basic (in shares)	62,439,857	52,664,349
Diluted (in shares)	62,439,857	52,664,349